194 related articles for article (PubMed ID: 7511740)
1. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.
Oksa A; Gajdos M; Fedelesová V; Spustová V; Dzúrik R
J Cardiovasc Pharmacol; 1994 Jan; 23(1):79-86. PubMed ID: 7511740
[TBL] [Abstract][Full Text] [Related]
2. Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.
Böhlen L; Bienz R; Doser M; Papiri M; Shaw S; Riesen W; Weidmann P
J Cardiovasc Pharmacol; 1996 Jun; 27(6):770-6. PubMed ID: 8761842
[TBL] [Abstract][Full Text] [Related]
3. Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients.
Thürig C; Böhlen L; Schneider M; de Courten M; Shaw SG; Riesen W; Weidmann P
Eur J Clin Pharmacol; 1995; 49(1-2):21-6. PubMed ID: 8751016
[TBL] [Abstract][Full Text] [Related]
4. Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients.
Bak JF; Gerdes LU; Sørensen NS; Pedersen O
Am J Med; 1992 Apr; 92(4B):69S-72S. PubMed ID: 1580283
[TBL] [Abstract][Full Text] [Related]
5. Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia.
Middeke M; Krone W
J Cardiovasc Pharmacol; 1994 Apr; 23(4):629-31. PubMed ID: 7516014
[TBL] [Abstract][Full Text] [Related]
6. Glucose and lipid metabolism in essential hypertension: effects of diuretics and ACE-inhibitors.
De Cesaris R; Ranieri G; Filitti V; Andriani A; Lamontanara G
Cardiology; 1993; 83(3):165-72. PubMed ID: 8281530
[TBL] [Abstract][Full Text] [Related]
7. Glucose and lipid metabolism during long-term treatment with cilazapril in hypertensive patients with or without impaired glucose metabolism.
Shionoiri H; Sugimoto K; Minamisawa K; Ueda S; Ebina T; Matsukawa T; Gotoh E; Ishii M
J Cardiovasc Pharmacol; 1990 Jun; 15(6):933-8. PubMed ID: 1694916
[TBL] [Abstract][Full Text] [Related]
8. Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.
Anichkov DA; Shostak NA; Schastnaya OV
Curr Med Res Opin; 2005 Jan; 21(1):113-9. PubMed ID: 15881482
[TBL] [Abstract][Full Text] [Related]
9. Effect of cilazapril therapy on glucose and lipid metabolism in patients with hypertension.
Shionoiri H; Takasaki I; Naruse M; Nagamoti I; Himeno H; Ito T; Ohtomi S; Hata T; Shindo K; Mikami H
Clin Ther; 1995; 17(6):1126-35. PubMed ID: 8750404
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte-suppressing action of angiotensin-converting enzyme inhibitors in coronary artery disease patients with normal blood pressure.
Krysiak R; Okopień B
Pharmacol Rep; 2011; 63(5):1151-61. PubMed ID: 22180357
[TBL] [Abstract][Full Text] [Related]
11. Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril.
Alcocer L; Campos C; Bahena JH; Nacaud A; Parra Carillo J; Calvo C; Weber C; Lerebours G; Mickalonis L; Villahermosa MT
Cardiovasc Drugs Ther; 1995 Jun; 9(3):431-6. PubMed ID: 8527353
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
Hakamäki T; Lehtonen A
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
[TBL] [Abstract][Full Text] [Related]
13. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
[TBL] [Abstract][Full Text] [Related]
15. [Effect of angiotensin converting enzyme inhibitors on lipid, purine and glucose metabolism].
Buemi M; Frisina N
Recenti Prog Med; 1989 Feb; 80(2):78-82. PubMed ID: 2540515
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.
Santoro D; Natali A; Palombo C; Brandi LS; Piatti M; Ghione S; Ferrannini E
Hypertension; 1992 Aug; 20(2):181-91. PubMed ID: 1639459
[TBL] [Abstract][Full Text] [Related]
17. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure.
Fliser D; Rett K; Hübinger A; Ritz E
Nephrol Dial Transplant; 1995; 10(5):643-7. PubMed ID: 7566576
[TBL] [Abstract][Full Text] [Related]
18. Insulin sensitivity in obese hypertensive dyslipidemic patients treated with enalapril or atenolol.
Morel Y; Gadient A; Keller U; Vadas L; Golay A
J Cardiovasc Pharmacol; 1995 Aug; 26(2):306-11. PubMed ID: 7475056
[TBL] [Abstract][Full Text] [Related]
19. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
Uchida K; Azukizawa S; Kigoshi T; Nakano S; Kaneko M; Morimoto S; Matsui A
Clin Ther; 1994; 16(3):466-70. PubMed ID: 7923313
[TBL] [Abstract][Full Text] [Related]
20. Effects of perindopril on carbohydrate and lipoprotein metabolism in essential hypertension.
Giuntoli F; Gabbani S; Natali A; Galeone F; Saba P
Am J Med; 1992 Apr; 92(4B):95S-97S. PubMed ID: 1580289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
